PACIRA BIOSCIENCES, INC. Unrealized Gain (Loss) on Investments
PACIRA BIOSCIENCES, INC. (PCRX) reported Unrealized Gain (Loss) on Investments of $4.00 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2020-05-07
- PACIRA BIOSCIENCES, INC. unrealized gain (loss) on investments for the quarter ending 2020-03-31 was $4.00M.
- PACIRA BIOSCIENCES, INC. unrealized gain (loss) on investments for the quarter ending 2019-03-31 was $0.00.
- PACIRA BIOSCIENCES, INC. unrealized gain (loss) on investments for the quarter ending 2018-09-30 was $5.40M.
- PACIRA BIOSCIENCES, INC. unrealized gain (loss) on investments for fiscal 2019 was $5.70M.
| Period end | Unrealized Gain (Loss) on Investments 3 month | Unrealized Gain (Loss) on Investments 12 month |
|---|---|---|
| 2020-03-31 | $4.00M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $5.70M 10-K · filed 2020-02-21 | |
| 2019-03-31 | $0.00 10-Q · filed 2020-05-07 | |
| 2018-09-30 | $5.40M 10-Q · filed 2019-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |